FEATURED TRIALS
Graves' Disease
We're conducting a study to see if BHV-1300 is a safe treatment for people with Graves' Disease.
Drug: BHV-1300
Age: 18-65
Phase: 1
Parkinson's Disease
Researching an investigational treatment to change the course of Parkinson's disease.
Drug: BHV-8000
Age: 40-85
Phase: 2/3
Generalized Epilepsy
Researching an Investigational Treatment Option for Idiopathic Generalized Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 3
FOCAL EPILEPSY
Researching an investigational treatment option for Focal Onset Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 2/3
Major Depressive Disorder
A Study to Evaluate the Efficacy and Safety of BHV-7000 Monotherapy in Major Depressive Disorder
Drug: BHV-7000
Age: 18-75
Phase: 2